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AMPK  Subunit Targets Metabolic
Stress Sensing to Glycogen
163)) is most closely related to isoamylase domains [8]
found in glycoside hydrolase family 13, which includes
glycogen and starch branching enzymes [9], and is more
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in glycogen and starch branching enzymes, have notDartmouth Medical School
Hanover, New Hampshire 03755-3833 been shown formally to associate with either carbohy-
drate, but we demonstrate that -GBD belongs to this
family and show that it binds glycogen. Thus, -GBD
represents a new subfamily of glycogen bindingSummary
modules.
The -GBD sequence is highly conserved across theAMP-activated protein kinase (AMPK) is a multisub-
strate enzyme activated by increases in AMP during AMPK/SNF1  subfamily (Figure 3A). We constructed a
3D homology model of -GBD (Figure 3B) based onmetabolic stress caused by exercise, hypoxia, lack
of cell nutrients [1], as well as hormones, including aligning residues 68–163 of the rat AMPK 1 subunit
with the three known isoamylase domain structures [8,adiponectin and leptin [2, 3]. Furthermore, metformin
and rosiglitazone, frontline drugs used for the treat- 11, 12]. Inspection of the model revealed two surface-
exposed tryptophans and a lysine (W100, K126, andment of type II diabetes, activate AMPK [4]. Mamma-
lian AMPK is an  heterotrimer with multiple iso- W133) that together formed a putative carbohydrate
binding site (Figure 3C) that is strikingly similar to bind-forms of each subunit comprising 1, 2, 1, 2, 1,
2, and 3, which have varying tissue and subcellular ing site 1 in the glucoamylase and cyclodextrin glycosyl-
transferase starch binding domains [13, 14]. When mal-expression [5, 6]. Mutations in the AMPK  subunit
cause glycogen storage disease in humans [7], but totriose was modeled into the glycogen binding site, the
apolar faces of two sugars stacked against the aromaticthe molecular relationship between glycogen and the
AMPK/Snf1p kinase subfamily has not been apparent. rings of W100 and W133 (Figure 3C). The dual specificity
phosphatase laforin (Figure 1B) contains a glycogenWe show that the AMPK  subunit contains a func-
tional glycogen binding domain (-GBD) that is most binding domain belonging to the more distally related
CBM family 20 and shares the equivalent residues ofclosely related to isoamylase domains found in glyco-
gen and starch branching enzymes. Mutation of key W100, K126, and W133. Mutation of these residues also
prevents laforin binding to glycogen [15].glycogen binding residues, predicted by molecular
modeling, completely abolished -GBD binding to gly- We show that mutation of putative key binding resi-
dues of -GBD, W100G and K126Q, completely abol-cogen. AMPK binds to glycogen but retains full activ-
ity. Overexpressed AMPK 1 localized to specific ished -GBD binding to glycogen, whereas the W133L
mutation only partially inhibited binding (Figure 3D). Mu-mammalian subcellular structures that corresponded
with the expression pattern of glycogen phosphory- tation of the AMPK  autophosphorylation site S108
contained within the -GBD [16] to glutamic acid par-lase. Glycogen binding provides an architectural link
tially inhibited glycogen binding (Figure 3D), whereasbetween AMPK and a major cellular energy store and
alanine had no effect. In yeast, the  homolog, Gal83p,juxtaposes AMPK to glycogen bound phosphatases.
contains a mutation (G235R) within its glycogen binding
domain [17] that causes the Snf1p substrate Sip4p (aResults and Discussion
transcriptional activator) to become insensitive to glu-
cose suppression [18]. We find that the equivalentA putative domain of the AMPK  subunit contained
G147R mutation in -GBD partially inhibited glycogenwithin residues 42–183 was identified by using sequence
binding (Figure 3D). Arg at position 147 would be ex-searches and secondary structure predictions (Figure
pected to distort the glycogen binding site by electro-1A). Limited proteolysis of AMPK-1(42–183) revealed a
static repulsion of Lys-126 in the -GBD model structureprotease-resistant fragment corresponding to residues
(Figure 3C). Gal83p may therefore be important for re-68–163 (-GBD). The -GBD sequence (AMPK-1(68–
cruiting Sip4p to glycogen to allow inactivation by glyco-
gen bound phosphatases in the presence of glucose.*Correspondence: davids@medstv.unimelb.edu.au
4These authors contributed equally to this work. We used purified rat liver AMPK to confirm that the
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Figure 1. AMPK 1 Contains a Proteolysis-Resistant Domain that
Is Related to the Starch and Glycogen Binding Domain Superfamily
(A) Bioinformatic analysis identified a potential midmolecule domain
in the AMPK  subunit. Limited proteolysis analysis with the specific
proteases chymotrypsin (Chymo), Asp-N, and Lys-C identified the
domain between residues 68 and 163.
(B) The relationship between AMPK 1(68–163) and other known
starch or glycogen binding domains was determined by unrooted
phylogenetic tree analysis as determined by the AllAll server (http://
cbrg.inf.ethz.ch/Server/AllAll.html).
Figure 2. Interaction of -GBD (AMPK 1(68–163)) with Glycogen
holoenzyme binds to glycogen (Figure 4). But, AMPK
(A) -GBD associates with glycogen. The inset shows the relative
binding to glycogen required 10-fold higher concentra- amount of -GBD protein bound to glycogen for the corresponding
tions of -cyclodextrin to prevent binding (data not amounts of added -GBD (g), as assessed by Coomassie staining
of a Tris-tricine gel.shown), indicating that its binding is stronger than
(B) -cyclodextrin (-CD) competes for binding of glycogen to-GBD alone. This may be due to more favorable posi-
-GBD, and half maximal inhibition occurs with 1.5 mMtioning of the -GBD within the context of the holoen-
-cyclodextrin. The insert shows Coomassie staining of a Tris-tricinezyme and may reduce the AMPK dissociation rate from
gel from this experiment.
glycogen. Since several studies have reported that acti-
vation of AMPK is reduced in tissues containing high
levels of glycogen [19, 20], we tested the effect of glyco- tains a glycogen binding domain that targets AMPK to
glycogen (Figure 5). Several lines of evidence now linkgen and found that it did not affect the activity of AMPK
directly (Figure 4). To study the subcellular localization AMPK to glycogen metabolism. The yeast homolog
Snf1p is important for maintaining glycogen levels [22].of the AMPK 1 subunit, we transiently expressed 1-
GFP in COS-7 cells together with glycogen phosphory- Glycogen synthase, an AMPK substrate [19], and glyco-
gen phosphorylase coimmunoprecipitate with AMPKlase (GP) tagged to Discosoma sp. red fluorescent pro-
tein. AMPK 1-GFP colabeled glycogen bodies with GP, [6]. Mutation in AMPK 3 (R200Q) causes glycogen ac-
cumulation and reduced meat quality in Hampshire pigsas shown in Figure 5, and thereby demonstrated that
AMPK localizes to glycogen in vivo. The glycogen bodies [23]. By contrast, reduced muscle glycogen and im-
proved meat yields are linked to the adjacent V199I 3were similar in size and shape to those reported when
the dual-specificity phosphatase laforin was overex- variant [24]. In humans, six mutations in AMPK 2 have
been found in individuals exhibiting cardiac hypertrophypressed [15] and to those reported in the companion
paper [21], which reports that AMPK 1/2 colocalized due to glycogen accumulation in cardiomyocytes and
ventricular preexcitation typical of the Wolff-Parkinson-with glycogen synthase.
In summary, we show that the AMPK  subunit con- White (WPW) syndrome [7]. Thus, just as the AMPK
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Figure 3. Molecular Basis for Glycogen Binding to -GBD
(A) Structural alignment of the Snf1 family of  subunits based on the structure of the E. coli glycogen branching enzyme (GBE, accession
number P07762) [11]. Rat AMPK 1 -GBD (accession number P80386), human AMPK 1 (accession number Q9Y478), human AMPK 2
(accession number NP_005390), S. cerevisiae GAL83 (accession number Q04739), C. elegans AMPK 2 (accession number NP_499446), A.
thalania AMPK 1 (accession number NP_197615), and Z. mays AKINbetagamma-1 (accession number AAG31751) are shown. Amino acid
sequences were aligned with Clustalw and were formatted by an Excel macro as previously described [5]. Conserved amino acids are shaded
black, and conserved substitutions are shaded gray. Residues highlighted by an asterix have been mutated (see [D]). The arrows above the
sequences indicate predicted  strands 1–7c of the model.
(B) A ribbon representation of the GBD model shown as a  sandwich, with two antiparallel  sheets (colored green and purple), was based
on the structural alignment of N-isoamylase domains (PDB entries 1M7X, 1EH9, and 1BF2). Residues conserved across the larger starch and
glycogen binding domain family are labeled orange, while AMPK-specific residues, including an autophosphorylation site at Ser-108, are
labeled black.
(C) Potential sugar binding mode for the GBD based on the crystal structure of cyclodextrin glycosyltransferase complexed with carbohydrate
(PDB entry 2DIJ). Maltotriose, a small polysaccharide (shown with dark bonds), and relevant residues are shown in ball-and-stick representation.
The dashed lines indicate possible hydrogen bonds.
(D) Identification of residues critical for binding of -GBD to glycogen. Residues important for binding to glycogen were predicted by the
structural alignment (shown in [A]) and the model (shown in [B]). Wild-type and mutant -GBD were incubated with glycogen; Western blots
of Tris-tricine gels of input, supernatant (glycogen unbound), and pellet (glycogen bound) -GBD are shown. As predicted from the model
shown in (B), essential residues include W100 and K126; W133 and G147 also contribute to glycogen binding.
 subunit mutations can cause disorders of glycogen mechanism of how AMPK associates with glycogen. To
begin to explore these questions, we have crystallizedmetabolism [7], mutations in the AMPK  subunit can
be anticipated to interfere with glycogen metabolism. recombinant AMPK 1(68–163) with crystals diffracting
to beyond 2.2 A˚ resolution.Glycogen plays an important role in targeting many
different proteins [25], including glycogenin, glycogen
phosphorylase, glycogen synthase, phosphatases, and Supplemental Data
now AMPK, as depicted in Figure 6. Further studies will Supplemental Data including the Experimental Procedures are avail-
able at http://images.cellpress.com/supmat/supmatin.htm.be required to understand the regulation and precise
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Figure 4. Effect of Glycogen on AMPK Activity
Purified rat liver AMPK () was incubated in the presence and
absence of 30 mg/ml glycogen and was then centrifuged; AMPK
activity was measured in the supernatant (S) and pellet (P). AMPK
Figure 6. Schematic Representation of Glycogen Acting as a Scaf-bound to glycogen, but AMPK activity was not inhibited by glycogen.
fold that Links AMPK to a Major Cellular Energy Store as Well asData are shown as mean  SEM, n  6.
Juxtaposes AMPK to Glycogen Bound Phosphatases, Glycogen
Phosphorylase, and Glycogen Synthase
Glycogen is shown as a branched structure. PP1, protein phospha-
tase 1; PTG, protein targeting to glycogen [26].
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